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1. Introduction 
The natural history of valvular aortic stenosis (AS) is characterized by a protracted symptom 
free period during which morbidity and mortality are very low. During this period the 
average decrease in the aortic valve area is about 0.1 cm2 per year (1-4), although it is 
impossible to predict the rate of progression in an individual patient. For this reason, 
regular clinical follow-up is standard of care in all patients with asymptomatic mild to 
moderate AS (1). The onset of symptoms such as: angina, syncope, or heart failure 
significantly changes prognosis, with an average survival of 60% at 1 year and has increased 
risk of sudden cardiac death (5-7).  
2. Identifying high risk asymptomatic patients with severe AS 
Aortic valve replacement (AVR) is the current standard treatment for patients with severe 
AS who have symptoms or left ventricular (LV) systolic dysfunction (1, 2). However, the 
best treatment strategy in asymptomatic patients with severe AS and preserved LV systolic 
function is debated (8). Conservative approach with a watchful waiting is generally favored 
although the utility of early elective AVR has been debated in subset of high risk patients. 
Several predictors have been proposed which predict poor outcomes in patients with 
asymptomatic severe AS. These include stress testing, severity of AS, rapid hemodynamic 
progression of AS, elevated left atrial pressure as assessed by E/E’ using tissue Doppler 
imaging or atrial natriuretic peptide (NPA). Of these stress testing is the most validated way 
of identifying asymptomatic patients who may benefit from AVR (9-10). 
3. Importance of stress testing 
Improved life expectancy has resulted in there being more elderly patients with AS, in 
whom the true symptoms may be underestimated (11). Given the slow progression of 
disease, patients may reduce their level of physical activity to avoid or minimize symptoms 
and be unaware of subtle changes in effort tolerance or attribute it to deconditioning or a 
physical impact due to aging. The accurate determination of symptoms is crucial; as 
symptoms increase the risk of sudden death worsens as well as protend an overall worst 
prognosis (12-13).  
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Valvular heart disease has a varying dynamic components which depend on loading 
conditions, ventricular contractility, ventricular contractile reserve, volume-dependent 
compliance of heart chambers, and ventricular arterial coupling. The current primary role of 
stress testing in asymptomatic severe aortic stenosis is to provide an objective assessment of 
functional capacity which is of the utmost importance in patients who often adapt and 
reduce their physical activity, thus masking the symptoms. In addition, exercise testing can 
identify changes in valvular as well as ventricular function and the changes in the valve 
gradient with the changes in forward flow and to differentiate true vs. pseudo aortic 
stenosis in the setting of low cardiac output. 
4. Indications of stress testing 
Valve replacement is indicated in the presence of symptoms and severe aortic stenosis. In 
such patients, stress testing is contraindicated. In contrast, exercise testing is recommended 
in asymptomatic patients with severe aortic stenosis. Exercise testing is strongly advocated 
in the European guidelines and is a grade IIb recommendation in the American College of 
Cardiology/American Heart Association (ACC/AHA) 2006 guidelines (1, 2). There is no 
prospective clinical trial on the use of stress testing in asymptomatic patients with severe AS 
as an indicator for aortic valve replacement. However, several retrospective small clinical 
studies have evaluated the predictive value of stress testing in asymptomatic severe AS (14-
26), as shown in figure 1 which has been adapted from the American Journal of Cardiology 
(9). In this meta-analysis there were no sudden deaths in the patients with normal stress test 
results after 1 year of follow-up, while 5% with abnormal stress test results had sudden 
cardiac death. Overall, 52 of 253 patients (21%) with normal stress test results had adverse 
cardiac events, compared with 156 of 238 (66%) with abnormal stress test results. Stress 
testing can be used for risk stratification and for deciding on the timing of AVR in 








Fig. 1. Utility of stress testing in predicting cardiac events in patients with Severe AS 
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5. Prevalence of stress testing 
The results of the Euro Heart Survey on Valvular Heart Disease revealed that stress testing 
is underused in Europe. Only about 5.7% of asymptomatic patients with severe AS undergo 
exercise testing (27). The reason for the low usage of stress testing include: concern about 
safety, lack of awareness of its utility and lack of randomized, prospective trials. Stress 
testing is considered low risk when performed in asymptomatic patients under medically 
supervised conditions (9).  
6. Types of stress test 
A symptom-limited exercise test is more physiologic than a dobutamine test and may be 
performed safely. Treadmill or upright bicycle ergometry are the most frequent tests and 
the choice is based on individual experience or equipment available in a given laboratory. 
Symptom-limited graded bicycle exercise in a semi-supine position may be preferable 
since it allows continuous two dimensional and Doppler echocardiographic examinations. 
Dobutamine stress echocardiography may be used to assess aortic valve compliance by 
plotting effective orifice area against flow at each stage of the dobutamine test. However, 
in asymptomatic patients with severe aortic stenosis it is less likely to be helpful in 
identifying patients with occult symptoms. In asymptomatic patients with severe AS 
exercise testing should be repeated every 6 months for severe aortic stenosis and every 
year for moderate aortic stenosis (14). Testing should be performed in laboratory 
equipped with a resuscitation cart in the presence of a physician so that potential 
complications can be treated effectively. 
7. Parameters to be evaluated on stress testing 
Total exercise time, maximum workload, peak heart rate and blood pressure and the 
reason for stopping the test are recorded. The criteria of an abnormal exercise test 
provided in the European recommendations are listed in table 1. It is essential to record 
the development of symptoms carefully, such as objective dyspnea, angina, dizziness or 
near-syncope. When Doppler echocardiography is obtained during exercise, aortic 
velocity–time integral can be regularly recorded from the same window to assess changes 
in mean pressure gradient.  
The assessment of exercise capacity often identifies symptoms that patient has not reported 
and has important prognostic significance as outlined in multiple clinical studies but simple 
stress testing fails to identify patients at higher risk for rapid disease progression (9). A 
representative example of ST changes during stress testing in a patient with AS is shown in 
figure 2. 
8. Pathophysiology during exercise 
Multiple studies have shown that the LV response to exercise is abnormal in apparently 
asymptomatic AS (24-29). Patients with apparently asymptomatic AS with symptoms 
detected during exercise testing have lower peak myocardial oxygen consumption and 
lower peak stroke index than those patients who remained asymptomatic (24). Studies have 
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Symptoms during exercise: dyspnea, angina, syncope or near syncope 
Fall in blood pressure or <20 mm Hg rise in systolic blood pressure during exercise 
<80% of normal level of exercise tolerance 
>2 mm ST segment depression during exercise (horizontal or down sloping, in comparison 
to baseline, not attributable to other causes) 
Ventricular arrhythmias 
Table 1. Criteria of an abnormal exercise test in patients with asymptomatic aortic stenosis 
 
 
Fig. 2. A representative example of ST changes in infero-lateral leads during stress testing in 
a patient with AS 
moderate AS but stroke volume was significantly decreased in symptomatic patients with 
severe AS both at rest and on exercise. Otto et al observed a decrease in stroke volume on 
exercise in asymptomatic patients with AS using Doppler echocardiography (15). Severe 
calcification has been reported to sometimes represent or be associated with a faster 
progression of the AS and a higher risk for the rapid progression to symptoms and events 
(8). Lancellotti et al demonstrated that an abnormal exercise response in patients with 
asymptomatic AS was mediated by impaired contractile reserve and a relatively large 
increase in gradient (21). Mare´chaux et al. showed the utility of risk stratification based on 
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the increase in the mean pressure gradient of >18mmHg as the most predictive of outcomes 
(24). Peak exercise LV ejection fraction is another parameter for risk stratification in patients 
with asymptomatic AS, if LVEF does not increase by ≥5% it indicates impaired contractile 
reserve, and it is suggestive of limited LV functional reserve (23). Aortic physiology due to 
altered compliance may play a role in the pathophysiology and progression of the disease, 
and this may become evident on stress testing. Some authors have noted a blunted fall in 
systemic vascular resistance associated with exercise induced symptoms (24-26). In short, 
AS, coronary disease and reduced aortic compliance exist as a continuum, and stress testing 
can play the critical role of revealing symptoms and subsequent referral for intervention. 
9. Clinical utility of stress testing 
The current ESC guidelines recommend AVR in patients who develop cardiac symptoms 
(class I) or who develop asymptomatic hypotension (class IIa) or asymptomatic ventricular 
arrhythmias (class IIb) during the exercise test (2). In contrast, the ACC/AHA guidelines 
recommend AVR if symptoms or hypotension appear during the exercise test (class IIb) 
(1).The divergent recommendations can be explained by the lack of definitive evidence from 
prospective clinical trials and subsequent different interpretation by the two groups. While, 
exercise stress testing is recommended in the management of asymptomatic patients with 
severe AS, exercise stress echocardiography is not routinely recommended in the current 
guidelines.  
No randomized trial has been conducted in patients with asymptomatic severe aortic 
stenosis (30). The risk of sudden death is low and is usually considered to be lower than the 
risk of operation. However, the mortality is rather high early after the onset of symptoms or 
if the patient is on a surgical waiting list. In some patients, symptoms are not identified, 
especially in elderly subjects who are rather inactive (31). On the other hand, dyspnea and 
chest pain may be non-specific. Exercise testing can identify a limited exercise capacity and 
unmask symptoms in about one-third of the apparently asymptomatic patients (32-33). The 
development of symptoms during exercise seems to be more predictive than the other 
criteria, but this needs to be confirmed. A significant increase in mean transaortic pressure 
gradient predicts a higher risk of cardiac events and has been shown to provide incremental 
prognostic information over clinical, resting Doppler echocardiographic and exercise testing 
(21,24). Further studies using novel echocardiographic techniques may provide additional 
understanding of the hemodyamics in patients with severe asymptomatic AS and refine the 
utility of stress testing in risk stratification of AS patients for AVR either surgical or by 
newer percutaneous techniques (34). 
 In summary, stress testing appears to be of value in unmasking the symptoms in otherwise 
asymptomatic patients who may have denial or who unconsciously limit their activity 
secondarily to progressive AS. In addition, in elderly patients, symptoms may not be 
identified because of inactivity, thus in these groups of asymptomatic patients stress testing 
readily provides an objective assessment of functional status. 
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